Brind.
  1. Calidi Biotherapeutics announced a public offering in San Diego on August 22, 2025, which was subsequently declared effective by the SEC.

Calidi Biotherapeutics appointed Eric Poma as CEO and held an investor webinar via RedChip on July 22, 2025.

1 report, 1 independent Updated Jul 22
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Calidi Biotherapeutics appointed Eric Poma as CEO and held an investor webinar via RedChip on July 22, 2025.

Keep exploring

Part of

Calidi Biotherapeutics announced a public offering in San Diego on August 22, 2025, which was subsequently declared effective by the SEC. All 2 developments

Coverage

Newest first; wire copies grouped
  • GlobeNewswireJoin Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on July 24 SAN DIEGO, July 22, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE Ame